Home | Articles
Published on:May 2023
Indian Journal of Pharmaceutical Education and Research, 2023; 57(2s):s434-s441.
Original Article | doi:10.5530/ijper.57.2s.51

Design and Development of Oxyclozanide Chewable Tablet Formulation Employing Quality by Design Approach

Authors and affiliation (s):

Yildiz Ozalp1,*, Adel Aboubakr1, 2, Motunrayo Mayowa Onayo1, Hassen Kebede1, Nailla Jiwa1, Nese Buket Aksu3

1Department of Pharmaceutical Technology, Faculty of Pharmacy, Near East University, Nicosia, CYPRUS.

2Department of Pharmaceutical and Industrial Pharmacy, Faculty of Pharmacy, Sebha University, Sebha City, LIBYA.

3Department of Pharmaceutical Technology, School of Pharmacy, Istanbul Altinbas University, Istanbul, TURKEY.


Background: The focus of this research was to identify undiscovered knowledge associated with the production of oxyclozanide tablets utilizing Quality by Design (QbD) in order to develop an ideal formulation that would guarantee constant product quality. The modern approach to formulation design and optimization essentially entails QbD which is a systemic method of pharmaceutical development and comprises of the design and development of formulations as well as manufacturing processes to meet the target product quality. Materials and Methods: Pre-formulation studies on excipient flow properties, compactibility and tabletability profiles, identification of Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) were carried out. An experimental design was adopted to investigate the effect of formulation and process variables (compression force, super-disintegrant type and concentration) on the CQAs using Modde Pro 12.1. The obtained results were used to generate a Design Space (DS) based on the study data. Results: Preformulation studies carried out on the core excipients used, gave an understanding to their tabletability and compactibility. Process parameters such a compaction force and formulation variables such as super-disintegrant concentration were studied within the framework of Quality by Design (QbD) and the new optimized formulation derived was tested and confirmed to be within the design space generated. Conclusion: At the end of the study, the aim was achieved; which was to implement pre-formulation studies and QbD to design a formulation containing Oxyclozanide (API) with a combination of excipients.

Keywords: Quality by Design (QbD), Oxyclozanide, Chewable tablet, Compactibility, Tabletability.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).


Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs